Skip to content
Screener

Biote Corp. BTMD Q3 2025 earnings

Reported November 5, 2025 · After market close

Revenue$48.0MBeat by $2.2M
EPS$0.22Beat by $0.17
Revenue estimate$45.8M
EPS estimate$0.05

Next report

Nov 4, 2026 (In 3 weeks)
Revenue estimate$44.0M
EPS estimate-$0.05

Financials

Q3 2025

Income statement

See full
Revenue$48.0M-6.7%
Gross profit$34.4M-4.7%
Operating income$8.3M-32.1%
Net income$8.2M-23.5%
EPS (diluted)$0.22-33.3%

Balance sheet

See full
Cash & equivalents$28.0M-26.6%
Total debt$106.4M-5.3%
Total equity-$72.8M+44.2%
Total assets$111.3M+9.9%

Cash flow

See full
Operating cash flow$14.1M-9.5%
CapEx$499.0K-67.8%
Free cash flow$13.6M-3.1%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$95.08M-45.0%
Enterprise value$173.44M-29.8%
P/E3.3×-20.8×
P/S0.5×-0.4×

Profitability

See full
Gross margin72.4%+2.5pp
Operating margin16.1%-1.7pp
Net margin14.7%+11.0pp
FCF margin17.6%-0.7pp

Returns & leverage

See full
Current ratio1×-0.5×

Segments

By product

See full
Product Revenue$47.0M-5.7%
Pellet Procedures Product Revenue$34.0M-10.4%
Dietary Supplements$11.2M+8.4%
Disposable Trocars Product Revenue$1.2M+14.6%
Shipping Fees And Other Product Revenue$566.0K+18.2%

FAQ

When did Biote Corp. report Q3 2025 earnings?
Biote Corp. (BTMD) reported Q3 2025 earnings on November 5, 2025 after market close.
What were Biote Corp.'s Q3 2025 revenue and EPS?
Biote Corp. reported revenue of $48.0M and eps of $0.22 for Q3 2025.
Did Biote Corp. beat estimates in Q3 2025?
Revenue beat the consensus estimate of $45.8M by $2.2M. EPS beat the consensus estimate of $0.05 by $0.17.
How did Biote Corp.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 6.7% from $51.4M a year earlier and eps declined 33.3% from $0.33.
Where can I find Biote Corp.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-266910) and the 10-Q periodic report (0001193125-25-272294) directly on SEC EDGAR. The filing index links above go to sec.gov.